These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 35091666)

  • 1. In vitro synergistic activity of colistin and teicoplanin combination against multidrug-resistant Acinetobacter spp.
    Rady OMSM; El-Attar L; Amine A
    J Antibiot (Tokyo); 2022 Mar; 75(3):181-184. PubMed ID: 35091666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of apramycin (EBL-1003) in combination with colistin, meropenem, minocycline or sulbactam against XDR/PDR Acinetobacter baumannii isolates from Greece.
    Galani I; Souli M; Katsala D; Karaiskos I; Giamarellou H; Antoniadou A
    J Antimicrob Chemother; 2024 May; 79(5):1101-1108. PubMed ID: 38501368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro synergy of colistin combinations against colistin-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae isolates.
    Vidaillac C; Benichou L; Duval RE
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4856-61. PubMed ID: 22751540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro synergistic antimicrobial activity of a combination of meropenem, colistin, tigecycline, rifampin, and ceftolozane/tazobactam against carbapenem-resistant Acinetobacter baumannii.
    Ju YG; Lee HJ; Yim HS; Lee MG; Sohn JW; Yoon YK
    Sci Rep; 2022 May; 12(1):7541. PubMed ID: 35534512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic activities of colistin combined with other antimicrobial agents against colistin-resistant Acinetobacter baumannii clinical isolates.
    Almutairi MM
    PLoS One; 2022; 17(7):e0270908. PubMed ID: 35830449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of in vitro synergy between polymyxin B or colistin in combination with 16 antimicrobial agents against multidrug-resistant Acinetobacter baumannii isolates.
    Wang Y; Ma Y; Xiong L; Wang X; Zhou Y; Chi X; Chen T; Fu H; Luo Q; Xiao Y
    J Microbiol Immunol Infect; 2024 Apr; 57(2):300-308. PubMed ID: 38350840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing effect of natural adjuvant, panduratin A, on antibacterial activity of colistin against multidrug-resistant Acinetobacter baumannii.
    Thadtapong N; Chaturongakul S; Napaswad C; Dubbs P; Soodvilai S
    Sci Rep; 2024 Apr; 14(1):9863. PubMed ID: 38684853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic Antimicrobial Effect of Colistin in Combination with Econazole against Multidrug-Resistant Acinetobacter baumannii and Its Persisters.
    Xie M; Chen K; Chan EW; Chen S
    Microbiol Spectr; 2022 Jun; 10(3):e0093722. PubMed ID: 35467374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of sulbactam and colistin/sulbactam efficacy against multiple resistant Acinetobacter baumannii blood isolates.
    Heydarlou MM; Durmaz G; Ibrahi M BMS
    Indian J Med Microbiol; 2022; 40(4):567-571. PubMed ID: 35817630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic Effects of a Probiotic Culture Extract and Antimicrobial Combinations against Multidrug-Resistant
    Lee JH; Kim J; Kim GY
    Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241179
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro evaluation of human intravenous immunoglobulin in combination with antimicrobials and human serum against multidrug-resistant isolates of Acinetobacter baumannii.
    de Lima FCG; de Araújo AR; do Nascimento AV; Bezerra Cavalcanti CL; Oliveira Júnior JB; Sandes JM; da Silva EM; de Freitas CF; Veras DL; Alves LC; Brayner FA
    Braz J Microbiol; 2023 Dec; 54(4):2845-2856. PubMed ID: 37904004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro evaluation of different antimicrobial combinations with and without colistin against carbapenem-resistant Acinetobacter baumannii clinical isolates.
    Müderris T; Dursun Manyaslı G; Sezak N; Kaya S; Demirdal T; Gül Yurtsever S
    Eur J Med Res; 2024 Jun; 29(1):331. PubMed ID: 38880888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models.
    Dudhani RV; Turnidge JD; Nation RL; Li J
    J Antimicrob Chemother; 2010 Sep; 65(9):1984-90. PubMed ID: 20573659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic Activity of Niclosamide in Combination With Colistin Against Colistin-Susceptible and Colistin-Resistant
    Ayerbe-Algaba R; Gil-Marqués ML; Jiménez-Mejías ME; Sánchez-Encinales V; Parra-Millán R; Pachón-Ibáñez ME; Pachón J; Smani Y
    Front Cell Infect Microbiol; 2018; 8():348. PubMed ID: 30338245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different surface charge of colistin-susceptible and -resistant Acinetobacter baumannii cells measured with zeta potential as a function of growth phase and colistin treatment.
    Soon RL; Nation RL; Cockram S; Moffatt JH; Harper M; Adler B; Boyce JD; Larson I; Li J
    J Antimicrob Chemother; 2011 Jan; 66(1):126-33. PubMed ID: 21081544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Verapamil increases susceptibility of colistin-resistant Acinetobacter baumannii to colistin.
    Liu S; Zhou H; Kong J; Chen H; Chen L; Tang M; Zhou B; Xu M; Chen L; Zhou T
    Int J Antimicrob Agents; 2024 Aug; 64(2):107233. PubMed ID: 38824971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic Antibacterial Effect of Phage pB3074 in Combination with Antibiotics Targeting Cell Wall against Multidrug-Resistant Acinetobacter baumannii
    Luo J; Xie L; Yang M; Liu M; Li Q; Wang P; Fan J; Jin J; Luo C
    Microbiol Spectr; 2023 Aug; 11(4):e0034123. PubMed ID: 37260382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiparasitic nitazoxanide potentiates colistin against colistin-resistant
    Xu M; Yao Z; Kong J; Tang M; Liu Q; Zhang X; Shi S; Zheng X; Cao J; Zhou T; Wang Z
    Microbiol Spectr; 2024 Jan; 12(1):e0229523. PubMed ID: 38032179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of colistin against heteroresistant Acinetobacter baumannii and emergence of resistance in an in vitro pharmacokinetic/pharmacodynamic model.
    Tan CH; Li J; Nation RL
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3413-5. PubMed ID: 17620384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of curcumin in combination with epigallocatechin gallate (EGCG) versus multidrug-resistant Acinetobacter baumannii.
    Betts JW; Wareham DW
    BMC Microbiol; 2014 Jun; 14():172. PubMed ID: 24969489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.